Cargando…
The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes
Cardiovascular diseases are the leading cause of mortality worldwide. In recent years, the relationship between carbonic anhydrase inhibitors and atherosclerosis has attracted attention. In this study, we aimed to determine the in vitro effects of 35 frequently used cardiac drugs on human carbonic a...
Autores principales: | Argan, Onur, Çıkrıkçı, Kübra, Baltacı, Aybike, Gencer, Nahit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717712/ https://www.ncbi.nlm.nih.gov/pubmed/32567385 http://dx.doi.org/10.1080/14756366.2020.1781844 |
Ejemplares similares
-
Evaluation of carbonic anhydrase and paraoxonase inhibition activities and molecular docking studies of highly water-soluble sulfonated phthalocyanines
por: GÜZEL, Emre, et al.
Publicado: (2020) -
Synthesis and In Vitro Inhibition Effect of New Pyrido[2,3-d]pyrimidine Derivatives on Erythrocyte Carbonic Anhydrase I and II
por: Kuday, Hilal, et al.
Publicado: (2014) -
Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfonamide on human erythrocyte carbonic anhydrase isozymes I and II
por: Büyükkıdan, Nurgün, et al.
Publicado: (2017) -
Structure and Dynamics
of the Isozymes II and IX of
Human Carbonic Anhydrase
por: Rai, Divya, et al.
Publicado: (2022) -
Carbonic Anhydrase Interaction With Lipothioars Enites: A Novel
Class of Isozymes I and II Inhibitors
por: Timotheatou, Despina, et al.
Publicado: (1996)